Reactivator Report for: Triple-binding-oxime-III-RGeneral | Type | | Oxime, Triazol | | Chemical_Nomenclature | | (2~{E})-~{N}-[(1~{R})-3-[4-[(2-methylimidazol-1-yl)methyl]-1,2,3-triazol-1-yl]-1-phenyl-propyl]-2-(oxidanylhydrazinylidene)ethanamide | | Canonical SMILES | | | | InChI | | InChI=1S/C18H22N8O2/c1-14-19-8-10-25(14)12-16-13-26(23-22-16)9-7-17(15-5-3-2-4-6-15)21-18(27)11-20-24-28/h2-6,8,10-11,13,17,24,28H,7,9,12H2,1H3,(H,21,27)/b20-11+/t17-/m1/s1 | | InChIKey | | NAPIHODYKNUSKS-MLHZQLSASA-N
| | Other name(s) | | MXB ; 2-(N-hydroxyimino)-N-[(1R)-3-{4-[(2-methyl-1H-imidazol-1-yl)methyl]-1H-1,2,3-triazol-1-yl}-1- phenylpropyl]acetamide |
________________________________________________________________________________________________ |
Target | Stucture | | | 1 structure: 6T9P: Structure of human butyrylcholinesterase in complex with R enantiomer of oxime III, methylimidazole derivative of 2-hydroxyimino-N-(azidophenylpropyl)acetamide |
|
|
|
